服务热线
15339069646服务热线
15339069646| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-MASP2 mAbs [Narsoplimab Biosimilar] (MABL-4967) | MABL-4967 | ELISA, FACS, Functional assay, in vivo binding | G4, Lambda |
| Anti-ITGA4/CD49D mAbs [Natalizumab Biosimilar] (MABL-4968) | MABL-4968 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-KLKB1 mAbs [Navenibart Biosimilar] (MABL-4969) | MABL-4969 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-AXL/UFO mAbs [Mipasetamab Biosimilar] (MABL-4938) | MABL-4938 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL3RA/CD123;CD3E mAbs [Mipletamig Biosimilar] (MABL-4939) | MABL-4939 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-LAG3/CD223 mAbs [Miptenalimab Biosimilar] (MABL-4940) | MABL-4940 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL23A mAbs [Mirikizumab Biosimilar] (MABL-4941) | MABL-4941 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-Rabies Virus Strain ERA Glycoprotein Ectodomain Epitope G-II mAbs [Miromavimab Biosimilar] (MAB | MABL-4942 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FOLR1 mAbs [Mirvetuximab Biosimilar] (MABL-4943) | MABL-4943 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-B7H3/CD276 mAbs [Mirzotamab Biosimilar] (MABL-4944) | MABL-4944 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MSLN mAbs [Misitatug Biosimilar] (MABL-4945) | MABL-4945 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF5/CD40 mAbs [Mitazalimab Biosimilar] (MABL-4946) | MABL-4946 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-ADPRC1/CD38 mAbs [Modakafusp Biosimilar] (MABL-4947) | MABL-4947 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-EGFR/ERBB1/HER1 mAbs [Modotuximab Biosimilar] (MABL-4948) | MABL-4948 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SIRPA mAbs [Moflerafusp Biosimilar] (MABL-4949) | MABL-4949 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CCR4/CD194 mAbs [Mogamulizumab Biosimilar] (MABL-4950) | MABL-4950 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-KLRC1 mAbs [Monalizumab Biosimilar] (MABL-4951) | MABL-4951 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD3E;MS4A1/CD20 mAbs [Mosunetuzumab Biosimilar] (MABL-4952) | MABL-4952 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa;Kappa |
| Anti-Respiratory Syncytial Virus Glycoprotein F mAbs [Motavizumab Biosimilar] (MABL-4953) | MABL-4953 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Masavibart Biosimilar] (MABL-4923) | MABL-4923 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn